Evidence map›Paper›PMID 28320186›Full record

ArticleJournal of the neurological sciences2017

Neurological complications after tuberculous meningitis in a multi-state cohort in the United States.

Alexander E Merkler, Alexandra S Reynolds, Gino Gialdini, Nicholas A Morris, Santosh B Murthy, Kiran Thakur, Hooman Kamel

Abstract read
In one paragraph

Article in Journal of the neurological sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 5 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 5 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Challenges in conducting trials for pediatric tuberculous meningitis: lessons from the field.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2019
    Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Acute ischemic stroke in tuberculous meningitis.Frontiers in public health · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Alexander E MerklerClinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, United States; Department of Neurology, Weill Cornell Medicine, New York, NY, United States. Electronic address: alm9097@med.cornell.edu.
Alexandra S ReynoldsDepartment of Neurology, Columbia University Medical Center, New York, NY, United States.
Gino GialdiniClinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, United States; Department of Neurology, Weill Cornell Medicine, New York, NY, United States.
Nicholas A MorrisClinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, United States; Department of Neurology, Weill Cornell Medicine, New York, NY, United States; Department of Neurology, Columbia University Medical Center, New York, NY, United States.
Santosh B MurthyClinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, United States; Department of Neurology, Weill Cornell Medicine, New York, NY, United States.
Kiran ThakurDepartment of Neurology, Columbia University Medical Center, New York, NY, United States.
Hooman KamelClinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, United States; Department of Neurology, Weill Cornell Medicine, New York, NY, United States.
MIND Research Institute · USColumbia University Irving Medical Center · USCornell University · US

Funding

Innovative PK/PD Approaches to Optimize TBM Treatment in Children (PATCH Study)R01HD074944 · NICHD · JOHNS HOPKINS UNIVERSITY · PI DOOLEY, KELLY E. · 2014 to 2019
$2.5M
Left Atrial abNormality, ThromboEmbolism, and Race: Novel risk factors for stroke (LANTERN)R01NS097443 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KAMEL, HOOMAN · 2016 to 2019
$1.5M
Atrial Fibrillation Precursors May Be Novel Stroke Risk FactorsK23NS082367 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KAMEL, HOOMAN · 2013 to 2017
$937k
NICHD NIH HHS R01 HD074944NINDS NIH HHS K23 NS082367NINDS NIH HHS R01 NS097443
6 · The paper itself

Abstract

background and purposeTo assess the rate of neurological complications and mortality after tuberculous meningitis in the United States.

methodsThe authors performed a retrospective cohort study of all patients 18years or older hospitalized for tuberculous meningitis in California between 2005 and 2010, New York between 2006 and 2012, and Florida between 2005 and 2012. Outcomes of interest were mortality and the following neurological complications: stroke, seizure, hydrocephalus requiring a ventriculoperitoneal shunt, vision impairment, and hearing impairment. Kaplan-Meier survival statistics were used to assess the cumulative rate of neurological complications and death. Cox proportional hazards regression was used to compare rates of complications in patients with and without human immunodeficiency virus (HIV) after adjustment for comorbidities.

results806 patients with tuberculous meningitis were identified, among whom the cumulative rate of any complication or death was 55.4% (95% CI, 51.5-59.3%). More than two-thirds of complications occurred during the initial hospitalization for tuberculous meningitis. Individual neurological complications were not uncommon: the cumulative rate of stroke was 16.8% (95% CI, 14.0-20.0%), the rate of seizure was 18.8% (95% CI, 15.4-22.8%), and the rate of ventriculoperitoneal shunting was 8.4% (95% CI, 6.4-10.9%). Vision impairment occurred in 21.6% (95% CI, 18.5-25.1%) of patients and hearing impairment occurred in 6.8% (95% CI, 4.9-9.4%). The mortality rate was 21.5% (95% CI, 18.4-24.9%). Patients with HIV infection were not at increased risk of complications compared to patients without HIV (hazard ratio, 1.2; 95% CI, 0.9-1.6).

conclusionsTuberculous meningitis is associated with significant risk of neurological complications and death in the United States.

Indexed as

AdultAgedCohort StudiesFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNervous System DiseasesProportional Hazards ModelsTreatment OutcomeTuberculosis, MeningealUnited StatesVentriculoperitoneal ShuntYoung AdultOutcome studiesSeizureStrokeTuberculous meningitisUnited StatesVentriculoperitoneal shunt

Identifiers

PMID28320186
PMCPMC5549847
OpenAlexW2589824467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.